Research

- 02.282026
  
  Walking the Right Path Together｜Lawyer Liu Yangfang: Over Two Decades of Devotion to Capital Markets Legal Services
  
  Studying with unwavering determination at Fudan University....
  
  see more
- 02.102026
  
  Legal Wisdom and Risk Prevention for Chinese Family Wealth Succession
  
  The horse steps on auspicious clouds, bringing blessings along....
  
  see more
- 02.052026
  
  Core Analysis of the New Regulations on Contracted Pharmaceutical Manufacturing: From "Holder's Sole Liability" to "Joint Liability"
  
  On January 27, 2026, the newly revised Regulations for the Implementation of the Drug Administration Law....
  
  see more
- 01.272026
  
  Compliance Control of Pharmaceutical Contract Sales Organization (CSO): Survival Strategies in the Era of In-depth Supervision and Bidding & Procurement Credit Evaluation (Part 2) | Sunbright Law Firm · Wolters Kluwer China Advance
  
  see more
- 01.262026
  
  4 Major Case Alerts! 2026 Pharmaceutical Anti-Corruption: Joint Analysis of "Criminal + Administrative + Bidding & Procurement Credit" Supervision
  
  In 2026, the anti-corruption campaign in the pharmaceutical sector has evolved from "case-by-case crackdowns" to "systematic governance".
  
  see more
- 01.262026
  
  Compliance Control of Pharmaceutical Contract Sales Organization (CSO): Survival Strategies in the Era of In-depth Supervision and Bidding & Procurement Credit Evaluation (Part 1) | Sunbright & Wolters Kluwer China Practice
  
  As the market-oriented reform of the pharmaceutical industry advances in depth.....
  
  see more